1. Home
  2. PNTG vs EVO Comparison

PNTG vs EVO Comparison

Compare PNTG & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Pennant Group Inc.

PNTG

The Pennant Group Inc.

HOLD

Current Price

$34.04

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.01

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNTG
EVO
Founded
2019
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
934.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
PNTG
EVO
Price
$34.04
$3.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$37.00
$7.00
AVG Volume (30 Days)
224.0K
85.0K
Earning Date
05-05-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
20.00
N/A
EPS
0.24
N/A
Revenue
$947,705,000.00
N/A
Revenue This Year
$24.72
$1.37
Revenue Next Year
$7.61
$10.05
P/E Ratio
$143.96
N/A
Revenue Growth
36.31
N/A
52 Week Low
$21.74
$2.31
52 Week High
$37.54
$4.48

Technical Indicators

Market Signals
Indicator
PNTG
EVO
Relative Strength Index (RSI) 52.96 53.04
Support Level $28.05 $2.88
Resistance Level $35.13 $3.36
Average True Range (ATR) 1.92 0.09
MACD -0.05 -0.01
Stochastic Oscillator 51.36 54.34

Price Performance

Historical Comparison
PNTG
EVO

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: